Clinical implications of percutaneous coronary intervention-Clopidogrel in unstable angina to prevent Recurrent Events (PCI-CURE) study - A US perspective

被引：41

作者：

Berger, PB

Steinhubl, S

机构：

[1] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA

[2] Univ N Carolina, Div Cardiol, Chapel Hill, NC USA

来源：

CIRCULATION | 2002年 / 106卷 / 17期

关键词：

D O I：

10.1161/01.CIR.0000035924.70846.20

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2284 / 2287

页数：4

共 16 条

[1] Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement [J].

Berger, PB ;

Bell, MR ;

Hasdai, D ;

Grill, DE ;

Melby, S ;

Holmes, DR .

CIRCULATION, 1999, 99 (02) :248-253

[2] Does ticlopidine reduce reocclusion and other adverse events after successful balloon angioplasty of occluded coronary arteries? Results from the Total Occlusion Study of Canada (TOSCA) [J].

Berger, PB ;

Dzavik, V ;

Penn, IM ;

Catellier, D ;

Buller, CE .

AMERICAN HEART JOURNAL, 2001, 142 (05) :776-781

[3] Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. [J].

Cannon, CP ;

Weintraub, WS ;

Demopoulos, LA ;

Vicari, R ;

Frey, MJ ;

Lakkis, N ;

Neumann, FJ ;

Robertson, DH ;

DeLucca, PT ;

DiBattiste, PM ;

Gibson, CM ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1879-1887

[4] Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. [J].

Gaspoz, J ;

Coxson, PG ;

Goldman, PA ;

Williams, LW ;

Kuntz, KM ;

Hunink, MGM ;

Goldman, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1800-1806

[5] The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting [J].

Hongo, RH ;

Ley, J ;

Dick, SE ;

Yee, RR .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (02) :231-237

[6] Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [J].

Mehta, SR ;

Yusuf, S ;

Peters, RJG ;

Bertrand, ME ;

Lewis, BS ;

Natarajan, MK ;

Maimberg, K ;

Rupprecht, HJ ;

Zhao, F ;

Chrolavicius, S ;

Copland, I ;

Fox, KAA .

LANCET, 2001, 358 (9281) :527-533

[7] Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention [J].

O'Shea, JC ;

Buller, CE ;

Cantor, WJ ;

Chandler, AB ;

Cohen, EA ;

Cohen, DJ ;

Gilchrist, IC ;

Kleiman, NS ;

Labinaz, M ;

Madan, M ;

Hafley, GE ;

Califf, RM ;

Kitt, MM ;

Strony, J ;

Tcheng, JE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (05) :618-621

[8] Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial [J].

Schühlen, H ;

Kastrati, A ;

Pache, J ;

Dirschinger, J ;

Schömig, A .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (04) :397-400

[9] The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctions [J].

Steinhubl, SR ;

Lauer, MS ;

Mukherjee, DP ;

Moliterno, DJ ;

Lincoff, AM ;

Ellis, SG ;

Topol, EJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) :1366-1370

[10] Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events - Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial [J].

Steinhubl, SR ;

Ellis, SG ;

Wolski, K ;

Lincoff, AM ;

Topol, EJ .

CIRCULATION, 2001, 103 (10) :1403-1409

← 1 2 →